INT J MED SCI 润色咨询

International Journal of Medical Sciences

出版年份:2004 年文章数:2227 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:4.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=807516, encodeId=2e9d80e516f6, content=审稿速度:2.0<br>经验分享:审稿41天,编辑发邮件告知没找到审稿人,但是没明确拒绝,让我继续推荐并添加审稿人信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Tue Aug 11 18:27:15 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591202, encodeId=3f3f5912029b, content=请问大家现在一审周期大概多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4ad2352929, createdName=jamjam, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月,催了三次,最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣,有两个审稿人给了意见,第一个审稿人就夸了夸,第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890894, encodeId=a1b98908942b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020.7.11 received 2020.9.14 major revision 2020.10.9 accept <a href='/topic/show?id=1613830e8bc' target=_blank style='color:#2F92EE;'>#肿瘤耐药性#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=83078, encryptionId=1613830e8bc, topicName=肿瘤耐药性)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Fri Oct 09 22:56:47 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801644, encodeId=945280164418, content=问一下大家,投稿两个月,一直under review.发送了submission status and related inquiry没有回应,发邮件咨询也没有回复。什么情况呢?大家遇到过吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a78f2534682, createdName=1250bb1dm75暂无昵称, createdTime=Tue Jul 07 19:19:14 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800035, encodeId=b3db800035b6, content=问一下,大修后多长时间能返回下一步意见,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca805160243, createdName=146b582em10暂无昵称, createdTime=Sat Jun 27 17:50:08 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889205, encodeId=be9488920563, content=投稿一周了,还是received状态,这是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f32507026, createdName=124af864m19暂无昵称, createdTime=Tue Sep 29 13:22:34 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011923, encodeId=5f39101192327, content=一直received,是没有under review状态吗,投过的大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Aug 27 08:52:09 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225695, encodeId=a28e1225695a7, content=经过2个月,拒稿,理由:没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc2c2386349, createdName=12324016m36暂无昵称, createdTime=Fri Jun 10 17:53:18 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894009, encodeId=d4a3894009a8, content=明年能过3分吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/09/bfd7b37871781bf56f192cf583960d1a.jpg, createdBy=a2c22314958, createdName=1223551em06暂无昵称, createdTime=Fri Oct 23 20:36:18 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-08-11 小汤圆有小心脏

    审稿速度:2.0
    经验分享:审稿41天,编辑发邮件告知没找到审稿人,但是没明确拒绝,让我继续推荐并添加审稿人信息

    11

    展开11条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=807516, encodeId=2e9d80e516f6, content=审稿速度:2.0<br>经验分享:审稿41天,编辑发邮件告知没找到审稿人,但是没明确拒绝,让我继续推荐并添加审稿人信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Tue Aug 11 18:27:15 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591202, encodeId=3f3f5912029b, content=请问大家现在一审周期大概多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4ad2352929, createdName=jamjam, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月,催了三次,最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣,有两个审稿人给了意见,第一个审稿人就夸了夸,第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890894, encodeId=a1b98908942b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020.7.11 received 2020.9.14 major revision 2020.10.9 accept <a href='/topic/show?id=1613830e8bc' target=_blank style='color:#2F92EE;'>#肿瘤耐药性#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=83078, encryptionId=1613830e8bc, topicName=肿瘤耐药性)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Fri Oct 09 22:56:47 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801644, encodeId=945280164418, content=问一下大家,投稿两个月,一直under review.发送了submission status and related inquiry没有回应,发邮件咨询也没有回复。什么情况呢?大家遇到过吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a78f2534682, createdName=1250bb1dm75暂无昵称, createdTime=Tue Jul 07 19:19:14 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800035, encodeId=b3db800035b6, content=问一下,大修后多长时间能返回下一步意见,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca805160243, createdName=146b582em10暂无昵称, createdTime=Sat Jun 27 17:50:08 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889205, encodeId=be9488920563, content=投稿一周了,还是received状态,这是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f32507026, createdName=124af864m19暂无昵称, createdTime=Tue Sep 29 13:22:34 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011923, encodeId=5f39101192327, content=一直received,是没有under review状态吗,投过的大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Aug 27 08:52:09 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225695, encodeId=a28e1225695a7, content=经过2个月,拒稿,理由:没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc2c2386349, createdName=12324016m36暂无昵称, createdTime=Fri Jun 10 17:53:18 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894009, encodeId=d4a3894009a8, content=明年能过3分吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/09/bfd7b37871781bf56f192cf583960d1a.jpg, createdBy=a2c22314958, createdName=1223551em06暂无昵称, createdTime=Fri Oct 23 20:36:18 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-05-19 jamjam

    请问大家现在一审周期大概多久?

    11

    展开11条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=807516, encodeId=2e9d80e516f6, content=审稿速度:2.0<br>经验分享:审稿41天,编辑发邮件告知没找到审稿人,但是没明确拒绝,让我继续推荐并添加审稿人信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Tue Aug 11 18:27:15 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591202, encodeId=3f3f5912029b, content=请问大家现在一审周期大概多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4ad2352929, createdName=jamjam, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月,催了三次,最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣,有两个审稿人给了意见,第一个审稿人就夸了夸,第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890894, encodeId=a1b98908942b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020.7.11 received 2020.9.14 major revision 2020.10.9 accept <a href='/topic/show?id=1613830e8bc' target=_blank style='color:#2F92EE;'>#肿瘤耐药性#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=83078, encryptionId=1613830e8bc, topicName=肿瘤耐药性)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Fri Oct 09 22:56:47 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801644, encodeId=945280164418, content=问一下大家,投稿两个月,一直under review.发送了submission status and related inquiry没有回应,发邮件咨询也没有回复。什么情况呢?大家遇到过吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a78f2534682, createdName=1250bb1dm75暂无昵称, createdTime=Tue Jul 07 19:19:14 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800035, encodeId=b3db800035b6, content=问一下,大修后多长时间能返回下一步意见,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca805160243, createdName=146b582em10暂无昵称, createdTime=Sat Jun 27 17:50:08 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889205, encodeId=be9488920563, content=投稿一周了,还是received状态,这是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f32507026, createdName=124af864m19暂无昵称, createdTime=Tue Sep 29 13:22:34 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011923, encodeId=5f39101192327, content=一直received,是没有under review状态吗,投过的大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Aug 27 08:52:09 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225695, encodeId=a28e1225695a7, content=经过2个月,拒稿,理由:没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc2c2386349, createdName=12324016m36暂无昵称, createdTime=Fri Jun 10 17:53:18 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894009, encodeId=d4a3894009a8, content=明年能过3分吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/09/bfd7b37871781bf56f192cf583960d1a.jpg, createdBy=a2c22314958, createdName=1223551em06暂无昵称, createdTime=Fri Oct 23 20:36:18 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-11-07 小汤圆有小心脏

    审稿4个月,催了三次,最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣,有两个审稿人给了意见,第一个审稿人就夸了夸,第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……

    8

    展开8条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=807516, encodeId=2e9d80e516f6, content=审稿速度:2.0<br>经验分享:审稿41天,编辑发邮件告知没找到审稿人,但是没明确拒绝,让我继续推荐并添加审稿人信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Tue Aug 11 18:27:15 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591202, encodeId=3f3f5912029b, content=请问大家现在一审周期大概多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4ad2352929, createdName=jamjam, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月,催了三次,最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣,有两个审稿人给了意见,第一个审稿人就夸了夸,第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890894, encodeId=a1b98908942b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020.7.11 received 2020.9.14 major revision 2020.10.9 accept <a href='/topic/show?id=1613830e8bc' target=_blank style='color:#2F92EE;'>#肿瘤耐药性#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=83078, encryptionId=1613830e8bc, topicName=肿瘤耐药性)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Fri Oct 09 22:56:47 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801644, encodeId=945280164418, content=问一下大家,投稿两个月,一直under review.发送了submission status and related inquiry没有回应,发邮件咨询也没有回复。什么情况呢?大家遇到过吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a78f2534682, createdName=1250bb1dm75暂无昵称, createdTime=Tue Jul 07 19:19:14 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800035, encodeId=b3db800035b6, content=问一下,大修后多长时间能返回下一步意见,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca805160243, createdName=146b582em10暂无昵称, createdTime=Sat Jun 27 17:50:08 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889205, encodeId=be9488920563, content=投稿一周了,还是received状态,这是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f32507026, createdName=124af864m19暂无昵称, createdTime=Tue Sep 29 13:22:34 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011923, encodeId=5f39101192327, content=一直received,是没有under review状态吗,投过的大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Aug 27 08:52:09 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225695, encodeId=a28e1225695a7, content=经过2个月,拒稿,理由:没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc2c2386349, createdName=12324016m36暂无昵称, createdTime=Fri Jun 10 17:53:18 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894009, encodeId=d4a3894009a8, content=明年能过3分吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/09/bfd7b37871781bf56f192cf583960d1a.jpg, createdBy=a2c22314958, createdName=1223551em06暂无昵称, createdTime=Fri Oct 23 20:36:18 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-10-09 奋斗党

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:2020.7.11 received 2020.9.14 major revision 2020.10.9 accept #肿瘤耐药性#

    7

    展开7条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=807516, encodeId=2e9d80e516f6, content=审稿速度:2.0<br>经验分享:审稿41天,编辑发邮件告知没找到审稿人,但是没明确拒绝,让我继续推荐并添加审稿人信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Tue Aug 11 18:27:15 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591202, encodeId=3f3f5912029b, content=请问大家现在一审周期大概多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4ad2352929, createdName=jamjam, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月,催了三次,最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣,有两个审稿人给了意见,第一个审稿人就夸了夸,第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890894, encodeId=a1b98908942b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020.7.11 received 2020.9.14 major revision 2020.10.9 accept <a href='/topic/show?id=1613830e8bc' target=_blank style='color:#2F92EE;'>#肿瘤耐药性#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=83078, encryptionId=1613830e8bc, topicName=肿瘤耐药性)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Fri Oct 09 22:56:47 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801644, encodeId=945280164418, content=问一下大家,投稿两个月,一直under review.发送了submission status and related inquiry没有回应,发邮件咨询也没有回复。什么情况呢?大家遇到过吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a78f2534682, createdName=1250bb1dm75暂无昵称, createdTime=Tue Jul 07 19:19:14 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800035, encodeId=b3db800035b6, content=问一下,大修后多长时间能返回下一步意见,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca805160243, createdName=146b582em10暂无昵称, createdTime=Sat Jun 27 17:50:08 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889205, encodeId=be9488920563, content=投稿一周了,还是received状态,这是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f32507026, createdName=124af864m19暂无昵称, createdTime=Tue Sep 29 13:22:34 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011923, encodeId=5f39101192327, content=一直received,是没有under review状态吗,投过的大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Aug 27 08:52:09 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225695, encodeId=a28e1225695a7, content=经过2个月,拒稿,理由:没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc2c2386349, createdName=12324016m36暂无昵称, createdTime=Fri Jun 10 17:53:18 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894009, encodeId=d4a3894009a8, content=明年能过3分吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/09/bfd7b37871781bf56f192cf583960d1a.jpg, createdBy=a2c22314958, createdName=1223551em06暂无昵称, createdTime=Fri Oct 23 20:36:18 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-07-07 1250bb1dm75暂无昵称

    问一下大家,投稿两个月,一直under review.发送了submission status and related inquiry没有回应,发邮件咨询也没有回复。什么情况呢?大家遇到过吗?

    7

    展开7条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=807516, encodeId=2e9d80e516f6, content=审稿速度:2.0<br>经验分享:审稿41天,编辑发邮件告知没找到审稿人,但是没明确拒绝,让我继续推荐并添加审稿人信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Tue Aug 11 18:27:15 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591202, encodeId=3f3f5912029b, content=请问大家现在一审周期大概多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4ad2352929, createdName=jamjam, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月,催了三次,最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣,有两个审稿人给了意见,第一个审稿人就夸了夸,第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890894, encodeId=a1b98908942b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020.7.11 received 2020.9.14 major revision 2020.10.9 accept <a href='/topic/show?id=1613830e8bc' target=_blank style='color:#2F92EE;'>#肿瘤耐药性#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=83078, encryptionId=1613830e8bc, topicName=肿瘤耐药性)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Fri Oct 09 22:56:47 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801644, encodeId=945280164418, content=问一下大家,投稿两个月,一直under review.发送了submission status and related inquiry没有回应,发邮件咨询也没有回复。什么情况呢?大家遇到过吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a78f2534682, createdName=1250bb1dm75暂无昵称, createdTime=Tue Jul 07 19:19:14 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800035, encodeId=b3db800035b6, content=问一下,大修后多长时间能返回下一步意见,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca805160243, createdName=146b582em10暂无昵称, createdTime=Sat Jun 27 17:50:08 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889205, encodeId=be9488920563, content=投稿一周了,还是received状态,这是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f32507026, createdName=124af864m19暂无昵称, createdTime=Tue Sep 29 13:22:34 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011923, encodeId=5f39101192327, content=一直received,是没有under review状态吗,投过的大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Aug 27 08:52:09 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225695, encodeId=a28e1225695a7, content=经过2个月,拒稿,理由:没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc2c2386349, createdName=12324016m36暂无昵称, createdTime=Fri Jun 10 17:53:18 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894009, encodeId=d4a3894009a8, content=明年能过3分吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/09/bfd7b37871781bf56f192cf583960d1a.jpg, createdBy=a2c22314958, createdName=1223551em06暂无昵称, createdTime=Fri Oct 23 20:36:18 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-06-27 146b582em10暂无昵称

    问一下,大修后多长时间能返回下一步意见,谢谢

    7

    展开7条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=807516, encodeId=2e9d80e516f6, content=审稿速度:2.0<br>经验分享:审稿41天,编辑发邮件告知没找到审稿人,但是没明确拒绝,让我继续推荐并添加审稿人信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Tue Aug 11 18:27:15 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591202, encodeId=3f3f5912029b, content=请问大家现在一审周期大概多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4ad2352929, createdName=jamjam, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月,催了三次,最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣,有两个审稿人给了意见,第一个审稿人就夸了夸,第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890894, encodeId=a1b98908942b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020.7.11 received 2020.9.14 major revision 2020.10.9 accept <a href='/topic/show?id=1613830e8bc' target=_blank style='color:#2F92EE;'>#肿瘤耐药性#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=83078, encryptionId=1613830e8bc, topicName=肿瘤耐药性)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Fri Oct 09 22:56:47 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801644, encodeId=945280164418, content=问一下大家,投稿两个月,一直under review.发送了submission status and related inquiry没有回应,发邮件咨询也没有回复。什么情况呢?大家遇到过吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a78f2534682, createdName=1250bb1dm75暂无昵称, createdTime=Tue Jul 07 19:19:14 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800035, encodeId=b3db800035b6, content=问一下,大修后多长时间能返回下一步意见,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca805160243, createdName=146b582em10暂无昵称, createdTime=Sat Jun 27 17:50:08 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889205, encodeId=be9488920563, content=投稿一周了,还是received状态,这是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f32507026, createdName=124af864m19暂无昵称, createdTime=Tue Sep 29 13:22:34 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011923, encodeId=5f39101192327, content=一直received,是没有under review状态吗,投过的大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Aug 27 08:52:09 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225695, encodeId=a28e1225695a7, content=经过2个月,拒稿,理由:没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc2c2386349, createdName=12324016m36暂无昵称, createdTime=Fri Jun 10 17:53:18 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894009, encodeId=d4a3894009a8, content=明年能过3分吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/09/bfd7b37871781bf56f192cf583960d1a.jpg, createdBy=a2c22314958, createdName=1223551em06暂无昵称, createdTime=Fri Oct 23 20:36:18 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-09-29 124af864m19暂无昵称

    投稿一周了,还是received状态,这是还没送审么

    6

    展开6条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=807516, encodeId=2e9d80e516f6, content=审稿速度:2.0<br>经验分享:审稿41天,编辑发邮件告知没找到审稿人,但是没明确拒绝,让我继续推荐并添加审稿人信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Tue Aug 11 18:27:15 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591202, encodeId=3f3f5912029b, content=请问大家现在一审周期大概多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4ad2352929, createdName=jamjam, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月,催了三次,最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣,有两个审稿人给了意见,第一个审稿人就夸了夸,第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890894, encodeId=a1b98908942b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020.7.11 received 2020.9.14 major revision 2020.10.9 accept <a href='/topic/show?id=1613830e8bc' target=_blank style='color:#2F92EE;'>#肿瘤耐药性#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=83078, encryptionId=1613830e8bc, topicName=肿瘤耐药性)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Fri Oct 09 22:56:47 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801644, encodeId=945280164418, content=问一下大家,投稿两个月,一直under review.发送了submission status and related inquiry没有回应,发邮件咨询也没有回复。什么情况呢?大家遇到过吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a78f2534682, createdName=1250bb1dm75暂无昵称, createdTime=Tue Jul 07 19:19:14 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800035, encodeId=b3db800035b6, content=问一下,大修后多长时间能返回下一步意见,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca805160243, createdName=146b582em10暂无昵称, createdTime=Sat Jun 27 17:50:08 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889205, encodeId=be9488920563, content=投稿一周了,还是received状态,这是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f32507026, createdName=124af864m19暂无昵称, createdTime=Tue Sep 29 13:22:34 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011923, encodeId=5f39101192327, content=一直received,是没有under review状态吗,投过的大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Aug 27 08:52:09 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225695, encodeId=a28e1225695a7, content=经过2个月,拒稿,理由:没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc2c2386349, createdName=12324016m36暂无昵称, createdTime=Fri Jun 10 17:53:18 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894009, encodeId=d4a3894009a8, content=明年能过3分吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/09/bfd7b37871781bf56f192cf583960d1a.jpg, createdBy=a2c22314958, createdName=1223551em06暂无昵称, createdTime=Fri Oct 23 20:36:18 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2021-08-27 丙丙

    一直received,是没有under review状态吗,投过的大佬们

    6

    展开6条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=807516, encodeId=2e9d80e516f6, content=审稿速度:2.0<br>经验分享:审稿41天,编辑发邮件告知没找到审稿人,但是没明确拒绝,让我继续推荐并添加审稿人信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Tue Aug 11 18:27:15 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591202, encodeId=3f3f5912029b, content=请问大家现在一审周期大概多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4ad2352929, createdName=jamjam, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月,催了三次,最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣,有两个审稿人给了意见,第一个审稿人就夸了夸,第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890894, encodeId=a1b98908942b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020.7.11 received 2020.9.14 major revision 2020.10.9 accept <a href='/topic/show?id=1613830e8bc' target=_blank style='color:#2F92EE;'>#肿瘤耐药性#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=83078, encryptionId=1613830e8bc, topicName=肿瘤耐药性)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Fri Oct 09 22:56:47 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801644, encodeId=945280164418, content=问一下大家,投稿两个月,一直under review.发送了submission status and related inquiry没有回应,发邮件咨询也没有回复。什么情况呢?大家遇到过吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a78f2534682, createdName=1250bb1dm75暂无昵称, createdTime=Tue Jul 07 19:19:14 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800035, encodeId=b3db800035b6, content=问一下,大修后多长时间能返回下一步意见,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca805160243, createdName=146b582em10暂无昵称, createdTime=Sat Jun 27 17:50:08 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889205, encodeId=be9488920563, content=投稿一周了,还是received状态,这是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f32507026, createdName=124af864m19暂无昵称, createdTime=Tue Sep 29 13:22:34 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011923, encodeId=5f39101192327, content=一直received,是没有under review状态吗,投过的大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Aug 27 08:52:09 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225695, encodeId=a28e1225695a7, content=经过2个月,拒稿,理由:没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc2c2386349, createdName=12324016m36暂无昵称, createdTime=Fri Jun 10 17:53:18 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894009, encodeId=d4a3894009a8, content=明年能过3分吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/09/bfd7b37871781bf56f192cf583960d1a.jpg, createdBy=a2c22314958, createdName=1223551em06暂无昵称, createdTime=Fri Oct 23 20:36:18 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2022-06-10 12324016m36暂无昵称

    经过2个月,拒稿,理由:没找到审稿人

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=807516, encodeId=2e9d80e516f6, content=审稿速度:2.0<br>经验分享:审稿41天,编辑发邮件告知没找到审稿人,但是没明确拒绝,让我继续推荐并添加审稿人信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Tue Aug 11 18:27:15 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591202, encodeId=3f3f5912029b, content=请问大家现在一审周期大概多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4ad2352929, createdName=jamjam, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月,催了三次,最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣,有两个审稿人给了意见,第一个审稿人就夸了夸,第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890894, encodeId=a1b98908942b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020.7.11 received 2020.9.14 major revision 2020.10.9 accept <a href='/topic/show?id=1613830e8bc' target=_blank style='color:#2F92EE;'>#肿瘤耐药性#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=83078, encryptionId=1613830e8bc, topicName=肿瘤耐药性)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Fri Oct 09 22:56:47 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801644, encodeId=945280164418, content=问一下大家,投稿两个月,一直under review.发送了submission status and related inquiry没有回应,发邮件咨询也没有回复。什么情况呢?大家遇到过吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a78f2534682, createdName=1250bb1dm75暂无昵称, createdTime=Tue Jul 07 19:19:14 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800035, encodeId=b3db800035b6, content=问一下,大修后多长时间能返回下一步意见,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca805160243, createdName=146b582em10暂无昵称, createdTime=Sat Jun 27 17:50:08 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889205, encodeId=be9488920563, content=投稿一周了,还是received状态,这是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f32507026, createdName=124af864m19暂无昵称, createdTime=Tue Sep 29 13:22:34 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011923, encodeId=5f39101192327, content=一直received,是没有under review状态吗,投过的大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Aug 27 08:52:09 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225695, encodeId=a28e1225695a7, content=经过2个月,拒稿,理由:没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc2c2386349, createdName=12324016m36暂无昵称, createdTime=Fri Jun 10 17:53:18 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894009, encodeId=d4a3894009a8, content=明年能过3分吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/09/bfd7b37871781bf56f192cf583960d1a.jpg, createdBy=a2c22314958, createdName=1223551em06暂无昵称, createdTime=Fri Oct 23 20:36:18 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-10-23 1223551em06暂无昵称

    明年能过3分吗?

    5

    展开5条回复
共293条页码: 1/30页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分